AGM Statement
11 Dezembro 2003 - 8:36AM
UK Regulatory
RNS Number:1364T
Ferraris Group PLC
11 December 2003
11 December 2003
Ferraris Group plc
AGM Statement
At the Annual General Meeting of Ferraris Group plc, held today, Ian Dighe,
Chairman, told shareholders:
"Further to the announcement in November of our intention to dispose of the
Group's Life Sciences Division, we are in contact with a number of potentially
interested buyers in both Europe and USA and we expect initial bids to be
received in the first quarter of 2004.
"Market conditions have not changed significantly since the Annual Report was
published with orders at the end of the first quarter in line with budget.
Clinical trials work is particularly encouraging and I am pleased to announce a
US contract gain of $340,000 for a new client; this work, primarily for
respiratory services, will be completed in the current financial year. There has
been an element of extra activity from the semi conductor sector but its
sustainability has yet to be established.
"The integration of Bionostics into the Group is complete and its management
team has already made a significant contribution within the Ferraris Group. The
reorganisation of the Respiratory Division is proceeding to plan; while the move
from Boston, Massachusetts to Denver, Colorado involves significant time and
effort to ensure a smooth transition without major disruption to the business,
an integrated unit in Denver should be operational by the end of March 2004. We
are finalising plans for the re-organisation of our European operations, which
we expect to complete by July 2004.
"I believe the Group is well placed to take advantage of the numerous
opportunities that will present themselves in the forthcoming period. It is
early in the new financial year but the Group has good growth prospects in its
core product areas."
- Ends -
For further information, please contact:
Ferraris Group plc 0121 782 6000
Ian Dighe, Chairman
Steven Mills, Chief Executive
Simon Dighton, Group Finance Director
Weber Shandwick Square Mile 020 7067 0700
Nick Oborne/ Rachel Lankester/ Susanne Walker
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMUAORROVRUAAA